Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 62
Filter
Add more filters










Publication year range
1.
Hum Exp Toxicol ; 41: 9603271221127429, 2022.
Article in English | MEDLINE | ID: mdl-36112883

ABSTRACT

BACKGROUND: As an aggressive human malignancy, esophageal squamous cell carcinoma (ESCC) is prevalent globally, especially in China. Verbascoside (VE) exerts anti-cancer effects in several human cancers. This work was to investigate the effects of VE on ESCC cells. METHODS: Esophageal squamous cell carcinoma cell proliferation, apoptosis, migration, and invasion were assessed by CCK-8, TUNEL, and Transwell assays. Gene and protein levels were detected by RT-qPCR and western blotting. CDC42 activity was evaluated by G-lisa assay. RESULTS: Verbascoside significantly inhibited cell proliferation, migration, and invasion and induced cell apoptosis in ESCC cells. Furthermore, it was found that VE markedly inhibited HMGB1 and RAGE expression in a dose-dependent manner. Besides, HMGB1/RAGE upregulation partially reversed the anti-cancer effects of VE on ESCC cells. VE repressed HMGB1/RAGE-induced CDC42 activation in ESCC cells. In addition, ML141-mediated CDC42 inactivation further enhanced the effect of VE on ESCC cell proliferation, apoptosis, migration, and invasion. CONCLUSIONS: Our findings indicated that VE has significant anti-tumor potential in ESCC by suppressing HMGB1/RAGE-dependent CDC42 activation.


Subject(s)
Esophageal Neoplasms , Esophageal Squamous Cell Carcinoma , Glucosides , Polyphenols , cdc42 GTP-Binding Protein , Cell Line, Tumor , Cell Movement , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/metabolism , Esophageal Squamous Cell Carcinoma/drug therapy , Esophageal Squamous Cell Carcinoma/genetics , Esophageal Squamous Cell Carcinoma/metabolism , Glucosides/pharmacology , Glucosides/therapeutic use , HMGB1 Protein/drug effects , HMGB1 Protein/metabolism , Humans , Neoplasm Invasiveness , Phenotype , Polyphenols/pharmacology , Polyphenols/therapeutic use , Receptor for Advanced Glycation End Products/drug effects , Receptor for Advanced Glycation End Products/metabolism , Sincalide/chemistry , cdc42 GTP-Binding Protein/drug effects , cdc42 GTP-Binding Protein/metabolism
2.
Nat Chem Biol ; 17(12): 1238-1244, 2021 12.
Article in English | MEDLINE | ID: mdl-34556862

ABSTRACT

Cholecystokinin A receptor (CCKAR) belongs to family A G-protein-coupled receptors and regulates nutrient homeostasis upon stimulation by cholecystokinin (CCK). It is an attractive drug target for gastrointestinal and metabolic diseases. One distinguishing feature of CCKAR is its ability to interact with a sulfated ligand and to couple with divergent G-protein subtypes, including Gs, Gi and Gq. However, the basis for G-protein coupling promiscuity and ligand recognition by CCKAR remains unknown. Here, we present three cryo-electron microscopy structures of sulfated CCK-8-activated CCKAR in complex with Gs, Gi and Gq heterotrimers, respectively. CCKAR presents a similar conformation in the three structures, whereas conformational differences in the 'wavy hook' of the Gα subunits and ICL3 of the receptor serve as determinants in G-protein coupling selectivity. Our findings provide a framework for understanding G-protein coupling promiscuity by CCKAR and uncover the mechanism of receptor recognition by sulfated CCK-8.


Subject(s)
Cholecystokinin/chemistry , Receptor, Cholecystokinin A/chemistry , Receptors, G-Protein-Coupled/chemistry , Sincalide/analogs & derivatives , Amino Acid Sequence , Benzodiazepinones/chemistry , Cryoelectron Microscopy , Humans , Ligands , Models, Molecular , Protein Binding , Protein Conformation , Protein Multimerization , Sincalide/chemistry , Triazoles/chemistry
3.
J Nucl Med Technol ; 48(2): 174-176, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32111658

ABSTRACT

This study aimed to evaluate the chemical stability of sincalide at 2 common storage conditions-room temperature and refrigeration-in an attempt to simulate the conditions faced during centralized reconstitution and subsequent distribution to regional clinical facilities. Sincalide is a peptide hormone product administered parenterally as an aid for diagnostic imaging of hepatobiliary conditions. With an estimated postreconstitution shelf-life of 8 h (updated by the manufacturer in 2014 with limited supporting data) and frequent shortages due to an intermittent supply, there is both clinical and economic value in the experimental determination of the true chemical stability of this agent. Methods: Sincalide was reconstituted and stored at both temperatures (n = 4 each), and samples were collected at predetermined time points. A validated high-performance liquid chromatography analytic method was used for quantification of the active ingredient in these samples. Results: Little to no chemical degradation of sincalide was observed for the duration of study, over 8 d, after reconstitution and storage at room temperature. A trend toward a cyclic fluctuation in concentration was also shared among all samples. A similar trend toward little to no chemical degradation and cyclic pattern was observed for the duration of study, over 8 d, after reconstitution and storage in refrigeration. Conclusion: This study supports that from a chemical standpoint, sincalide may potentially be used up to at least 8 d after reconstitution with sterile water, thus providing convenience and cost-saving benefits to medical institutions using the product. The findings of this study, however, warrant microbial testing over this storage duration before any recommendations for extended use can be made.


Subject(s)
Drug Storage/methods , Sincalide/chemistry , Water/chemistry , Chromatography, High Pressure Liquid , Drug Stability , Time Factors
5.
Int J Biol Macromol ; 85: 442-50, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26748068

ABSTRACT

Collagen constituting the extracellular matrix has been widely used as biocompatible material for human use. In this study, we have selected duck's feet for extracting collagen. A simple method not utilizing harsh chemical had been employed to extract collagen from duck's feet. We fabricated duck's feet collagen/silk hybrid scaffold for the purpose of modifying the degradation rate of duck's feet collagen. This study suggests that extracted collagen from duck's feet is biocompatible and resembles collagen extracted from porcine which is commercially used. Duck's feet collagen is also economically feasible and it could therefore be a good candidate as a tissue engineering material. Further, addition of silk to fabricate a duck's feet collagen/silk hybrid scaffold could enhance the biostability of duck's feet collagen scaffold. Duck's feet collagen/silk scaffold increased the cell viability compared to silk alone. Animal studies also showed that duck's feet collagen/silk scaffold was more biocompatible than silk alone and more biostable than duck's feet or porcine collagen alone. Additionally, the results revealed that duck's feet collagen/silk hybrid scaffold had high porosity, cell infiltration and proliferation. We suggest that duck's feet collagen/silk hybrid scaffold could be used as a dermal substitution for full thickness skin defects.


Subject(s)
Biocompatible Materials/chemistry , Collagen/chemistry , Silk/chemistry , Tissue Engineering , Tissue Scaffolds/chemistry , Animals , Cell Adhesion , Cell Line , Cell Survival , Ducks , Fibroins/chemistry , Male , Mice , Porosity , Rats , Sincalide/chemistry , Spectroscopy, Fourier Transform Infrared , Tissue Engineering/methods
6.
ACS Appl Mater Interfaces ; 7(44): 24656-62, 2015 Nov 11.
Article in English | MEDLINE | ID: mdl-26492561

ABSTRACT

Mussels survive by strongly attaching to a variety of different surfaces, primarily subsurface rocks composed of metal oxides, through the formation of coordinative interactions driven by protein-based catechol repeating units contained within their adhesive secretions. From a chemistry perspective, catechols are known to form strong and reversible complexes with metal ions or metal oxides, with the binding affinity being dependent on the nature of the metal ion. As a result, catechol binding with metal oxides is reversible and can be broken in the presence of a free metal ion with a higher stability constant. It is proposed to exploit this competitive exchange in the design of a new strategy for the formation, removal, and reformation of surface coatings and self-assembled monolayers (SAM) based on catechols as the adhesive unit. In this study, catechol-functionalized tri(ethylene oxide) (TEO) was synthesized as a removable and recoverable self-assembled monolayer (SAM) for use on oxides surfaces. Attachment and detachment of these catechol derivatives on a variety of surfaces was shown to be reversible and controllable by exploiting the high stability constant of catechol to soluble metal ions, such as Fe(III). This tunable assembly based on catechol binding to metal oxides represents a new concept for reformable coatings with applications in fields ranging from friction/wettability control to biomolecular sensing and antifouling.


Subject(s)
Bivalvia/chemistry , Metals/chemistry , Oxides/chemistry , 3T3 Cells , Adhesives , Animals , Biosensing Techniques , Catechols/chemistry , Cell Adhesion , Dihydroxyphenylalanine/chemistry , Ethylene Oxide/analogs & derivatives , Ethylene Oxide/chemistry , Eugenol/chemistry , Ferric Compounds , Ions , Mice , Photoelectron Spectroscopy , Silicon/chemistry , Sincalide/chemistry , Surface Properties , Wettability
7.
ACS Appl Mater Interfaces ; 7(44): 24629-40, 2015 Nov 11.
Article in English | MEDLINE | ID: mdl-26478947

ABSTRACT

Ischemic stroke causes extensive cellular loss that impairs brain functions, resulting in severe disabilities. No effective treatments are currently available for brain tissue regeneration. The need to develop effective therapeutic approaches for treating stroke is compelling. A tissue engineering approach employing a hydrogel carrying both cells and neurotrophic cytokines to damaged regions is an encouraging alternative for neuronal repair. However, this approach is often challenged by low in vivo cell survival rate, and low encapsulation efficiency and loss of cytokines. To address these limitations, we propose to develop a biomaterial that can form a matrix capable of improving in vivo survival of transplanted cells and reducing in vivo loss of cytokines. Here, we report that using sericin, a natural protein from silk, we have fabricated a genipin-cross-linked sericin hydrogel (GSH) with porous structure and mild swelling ratio. The GSH supports the effective attachment and growth of neurons in vitro. Strikingly, our data reveal that sericin protein is intrinsically neurotrophic and neuroprotective, promoting axon extension and branching as well as preventing primary neurons from hypoxia-induced cell death. Notably, these functions are inherited by the GSH's degradation products, which might spare a need of incorporating costly cytokines. We further demonstrate that this neurotrophic effect is dependent on the Lkb1-Nuak1 pathway, while the neuroprotective effect is realized through regulating the Bcl-2/Bax protein ratio. Importantly, when transplanted in vivo, the GSH gives a high cell survival rate and allows the cells to continuously proliferate. Together, this work unmasks the neurotrophic and neuroprotective functions for sericin and provides strong evidence justifying the GSH's suitability as a potential neuronal cell delivery vehicle for ischemic stroke repair.


Subject(s)
Brain Ischemia/pathology , Hydrogels/chemistry , Neurons/metabolism , Sericins/chemistry , Stroke/pathology , Tissue Engineering/methods , Animals , Biocompatible Materials/chemistry , Bombyx , Brain Ischemia/therapy , Cell Hypoxia , Cell Line , Cell Proliferation , Cell Survival , Cross-Linking Reagents/chemistry , Cytokines/metabolism , Glutathione Transferase/metabolism , Green Fluorescent Proteins/chemistry , Humans , Iridoids/chemistry , Mice , Mice, Inbred C57BL , Mice, Nude , Neurons/cytology , Neuroprotective Agents/chemistry , Porosity , Regeneration , Silk/chemistry , Sincalide/chemistry , Spectroscopy, Fourier Transform Infrared , Stroke/therapy
8.
Biomed Mater ; 10(1): 015019, 2015 Feb 10.
Article in English | MEDLINE | ID: mdl-25668049

ABSTRACT

To investigate the potential application of graphene oxide (GO) in bone repair, this study is focused on the preparation, characterization and cell behavior of graphene oxide coatings on quartz substrata. GO coatings were prepared on the substrata using a modified dip-coating procedure. Atomic force microscopy (AFM), scanning electron microscopy (SEM) and Raman spectroscopy results demonstrated that the as-prepared coatings in this study were homogeneous and had an average thickness of ~67 nm. The rapid formation of a hydroxyapatite (HA) layer in the simulated body fluid (SBF) on GO coated substrata at day 14, as proved by SEM and x-ray diffraction (XRD), strongly indicated the bioactivity of coated substrata. In addition, MC3T3-E1 cells were cultured on the coated substrata to evaluate cellular activities. Compared with the non-coated substrata and tissue culture plates, no significant difference was observed on the coated substrata in terms of cytotoxicity, viability, proliferation and apoptosis. However, interestingly, higher levels of alkaline phosphatase (ALP) activity and osteocalcin (OC) secretion were observed on the coated substrata, indicating that GO coatings enhanced cell differentiation compared with non-coated substrata and tissue culture plates. This study suggests that GO coatings had excellent biocompatibility and more importantly promoted MC3T3-E1 cell differentiation and might be a good candidate as a coating material for orthopedic implants.


Subject(s)
Biocompatible Materials/chemistry , Durapatite/chemistry , Graphite/chemistry , Orthopedics , Oxides/chemistry , 3T3 Cells , Alkaline Phosphatase/chemistry , Animals , Apoptosis , Body Fluids/chemistry , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Cell Survival , Culture Media/chemistry , Mice , Microscopy, Atomic Force , Microscopy, Electron, Scanning , Microscopy, Fluorescence , Osteocalcin/chemistry , Quartz , Sincalide/chemistry , Spectrum Analysis, Raman , Surface Properties , X-Ray Diffraction
9.
Mol Med Rep ; 11(2): 821-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25354708

ABSTRACT

Near­infrared fluorescence (NIRF) imaging is an attractive novel modality for the detection of cancer. A previous study defined two organic polymethine cyanine dyes as ideal NIRF probes, IR­783 and its derivative MHI­148, which have excellent optical characteristics, superior biocompatibility and cancer targeting abilities. To investigate the feasibility of NIRF dye­mediated prostate cancer imaging, dye uptake and subcellular co­localization were investigated in PC­3, DU­145 and LNCaP human prostate cancer cells and RWPE­1 normal prostate epithelial cells. Different organic anion transporting peptide (OATP) inhibitors were utilized to explore the potential role of the OATP subtype, including the nonspecific OATP inhibitor bromosulfophthalein, the OATP1 inhibitor 17ß­estradiol, the selective OATP1B1 inhibitor rifampicin and the selective OATP1B3 inhibitor cholecystokinin octapeptide. NIRF dyes were also used for the simulated detection of circulating tumor cells and the rapid detection of prostate cancer in human prostate cancer tissues and prostate cancer xenografts in mouse models. The results revealed that the cancer­specific uptake of these organic dyes in prostate cancer cells occurred primarily via OATP1B3. A strong NIRF signal was detected in prostate cancer tissues, but not in normal tissues that were stained with IR­783. Prostate cancer cells were recognized with particular NIR fluorescence in isolated mononuclear cell mixtures. The results of the present study demonstrated that NIRF dye­mediated imaging is a feasible and practicable method for prostate cancer detection, although further investigative studies are required before clinical translation.


Subject(s)
Carbocyanines/chemistry , Fluorescent Dyes/chemistry , Prostate/pathology , Prostatic Neoplasms/pathology , Animals , Cell Line , Estradiol/chemistry , Estradiol/metabolism , Flow Cytometry , Humans , Liver-Specific Organic Anion Transporter 1 , Male , Mice , Mice, Nude , Microscopy, Confocal , Neoplastic Cells, Circulating/pathology , Organic Anion Transporters/antagonists & inhibitors , Organic Anion Transporters/metabolism , Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors , Organic Anion Transporters, Sodium-Independent/metabolism , Organic Cation Transport Proteins/antagonists & inhibitors , Organic Cation Transport Proteins/metabolism , Prostate/metabolism , Prostatic Neoplasms/metabolism , Rifampin/chemistry , Rifampin/metabolism , Sincalide/chemistry , Sincalide/metabolism , Solute Carrier Organic Anion Transporter Family Member 1B3 , Spectroscopy, Near-Infrared , Sulfobromophthalein/chemistry , Sulfobromophthalein/metabolism , Transplantation, Heterologous
11.
Biopolymers ; 96(1): 88-96, 2011.
Article in English | MEDLINE | ID: mdl-20560147

ABSTRACT

New liposomal aggregates, prepared by combining together, in a 90:10 molar ratio, two amphiphilic monomers, one containing two hydrocarbon chains in the hydrophobic region and the anionic DOTA chelating agent as hydrophilic moiety, and the other containing the same hydrophobic moiety and the CCK8 peptide, are described. The liposomal aggregates because of the presence of the specific moiety, constituted by the CCK8 peptide, which selectively recognizes CCK receptors on tumor cells are used as drug carriers with the aim to deliver into tumor cells the appropriate antitumor drug. The drug loading content and the releasing properties of the liposomal aggregates are studied by the use of the cytotoxic doxorubicin as drug model. The doxorubicin loading content determination reveals that above 95% of the total drug was uptaken with a corresponding drug/lipid w/w ratio of 0.134. The cellular uptake of the targeted liposomal doxorubicin with respect to the self-assembled, nonspecific, liposomal doxorubicin is evaluated using flow cytometry assays. The doxorubicin cell content for two types of cell systems, namely, A431 and HuVEC cells, for peptide derivatized liposomes was 70- and 8-fold higher, respectively, than for nontargeted liposomes, indicating that the bioactive CCK8 peptide is able to enhance the doxorubicin uptake into the carcinoma cells in vitro. The cytotoxicity effect of liposomal doxorubicin on A431 cells has been assessed by MTT assays: in presence of drug amounts ranged between 250 and 1000 ng/ml, incubation with peptide derivatized liposomes showed significantly lower cell survival compared with nontargeted liposomes.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Doxorubicin/pharmacology , Drug Carriers/chemistry , Peptides/chemistry , Amino Acid Sequence , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Doxorubicin/administration & dosage , Doxorubicin/chemistry , Drug Carriers/chemical synthesis , Drug Delivery Systems/methods , Flow Cytometry , Heterocyclic Compounds, 1-Ring/chemistry , Humans , Liposomes/chemistry , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Receptors, Cholecystokinin/metabolism , Sincalide/chemistry , Sincalide/metabolism
12.
Biomed Chromatogr ; 24(2): 140-7, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19517450

ABSTRACT

The C-terminal octapeptide of cholecystokinin (CCK8) includes some easily oxidizable amino acids. The oxidation of CCK8 by reactive oxygen species (ROS) such as hydrogen peroxide (H(2)O(2)) and hydroxyl radicals (OH(*)) was investigated using reversed-phase high performance liquid chromatography (RP-HPLC) and subsequent electrospray ionization mass spectrometry. The mechanism of oxidation of CCK8 in the H(2)O(2) system differed from that of CCK8 in the Fenton system, in which OH(*) are produced. In the H(2)O(2) system, (28)Met and (31)Met were oxidized to methionine sulfoxide, and no further oxidation or degradation/hydrolysis occurred. On the other hand, in the Fenton system, (28)Met and (31)Met residues were oxidized to methionine sulfone via the formation of methionine sulfoxide. In addition, the oxidized product was observed at the Trp residue but not at the Tyr residue, and small peptide fragments from CCK8 were observed in the Fenton system. From these results, it was concluded that (28)Met and (31)Met residues of CCK8 are susceptible to oxidation by ROS.


Subject(s)
Reactive Oxygen Species/chemistry , Sincalide/chemistry , Amino Acids/chemistry , Chromatography, High Pressure Liquid , Glycosylation , Hydrogen Peroxide/chemistry , Iron , Oxidants/chemistry , Oxidation-Reduction , Phosphorylation , Spectrometry, Mass, Electrospray Ionization
14.
J Nucl Med Technol ; 37(1): 57-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19223430

ABSTRACT

UNLABELLED: Our objective was to compare the stability of Kinevac when reconstituted with sodium chloride injection, USP, 0.9%, versus the manufacturer's recommended sterile water for injection, USP, and to determine the effects on stability of deviating from the manufacturer's recommended methods of product preparation. METHODS: Kinevac was reconstituted with either sterile water or 0.9% sodium chloride. Triplicate high-performance liquid chromatography was performed on each vial of reconstituted sample at time zero and at time zero plus 8 h. The concentration of each sample, as measured by the peak area, was recorded at each time point. The process was repeated over 4 consecutive days. RESULTS: Kinevac reconstituted with sterile water resulted in the recovery of 89.73% of the time zero concentration after 8 h. Kinevac reconstituted with 0.9% sodium chloride resulted in chemical stability of the injection, with 80.05% recovery of the time zero value after 8 h. CONCLUSION: Kinevac is more stable when reconstituted with sterile water than when reconstituted with 0.9% sodium chloride. Kinevac should be reconstituted with sterile water for injection as per the manufacturer's instructions.


Subject(s)
Sincalide/chemistry , Sodium Chloride/chemistry , Chromatography, High Pressure Liquid , Drug Stability , Injections , Water
15.
J Med Chem ; 51(13): 3742-54, 2008 Jul 10.
Article in English | MEDLINE | ID: mdl-18540665

ABSTRACT

JMV-180 ( 1) and CCK-8(s) are high affinity ligands at the CCK 1 receptor that have similar and different actions via this receptor. Here we calculate the tertiary structure of 1 or CCK-8(s) in the presence of dodecylphosphocholine micelles at pH 5.0 and 35 degrees C from 2D (1)H NMR data recorded at 600 MHz. The NMR derived 3D structures of 1 and CCK-8(s) share a common type I beta-turn around residues Nle3/M3 and G4 and diverge from each other structurally at the N- and C-termini. The fluorescence and circular dichroism spectral properties of these peptides are consistent with their NMR derived structures. The structures determined in the presence of DPC micelles are compared to available models of 1 or CCK-8(s) bound to the CCK 1 receptor. For CCK and 1, these comparisons show that DPC micelle associated structures duplicate some important aspects of the models calculated from cross-linking derived constraints at the CCK 1 receptor.


Subject(s)
Micelles , Models, Molecular , Receptor, Cholecystokinin A/chemistry , Receptor, Cholecystokinin A/metabolism , Sincalide/chemistry , Circular Dichroism , Imaging, Three-Dimensional , Magnetic Resonance Spectroscopy , Protein Binding , Protein Structure, Tertiary , Sincalide/analogs & derivatives , Spectrometry, Fluorescence
16.
Electrophoresis ; 29(12): 2557-64, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18494034

ABSTRACT

Sulfation is a potentially important post-translational modification of proteins and has been demonstrated in a number of polypeptides, notably in gastrointestinal hormones. In contrast to phosphorylation, however, the investigation of sulfation patterns in tissues and on purified proteins has been complicated by the absence of specific immunoreagents (antibodies) for this modification as well as the chemical lability of the sulfate group. Here, we investigate the properties of a novel mAb against sulfated tyrosyl groups (anti-Tyr(SO(3)H) antibody) using CE and a panel of sulfated and nonsulfated peptides and proteins. The data show that the anti-Tyr(SO(3)H) antibody is completely specific for compounds containing sulfated tyrosyls. Affinity electrophoresis experiments allowed us to estimate dissociation constants for sulfated hirudin fragment (56-65), gastrin-17, and cholecystokinin octapeptide (CCK8) in the 1-3 microM range. The affinity of the antibody toward complement 4 protein that contains three sulfotyrosines was analyzed by surface plasmon resonance technology and modeled according to a bivalent-binding model which yielded a K(d1) of 20.1 microM for the monovalent complex. The same binding was studied by CE and found to be in the micromolar scale albeit with some uncertainty due to complex separation patterns. The work illustrates the amount of information on antibody-antigen interactions that may be obtained with microelectrophoretic methods consuming minute quantities of material. Furthermore the specificity of this antibody could be confirmed in one operation using an array of sulfated and nonsulfated compounds.


Subject(s)
Antibodies, Monoclonal/chemistry , Immunoglobulin G/chemistry , Tyrosine/analogs & derivatives , Antibody Affinity , Antibody Specificity , Complement C4/chemistry , Complement C4/immunology , Electrophoresis, Capillary , Gastrins/chemistry , Gastrins/immunology , Hirudins/chemistry , Hirudins/immunology , Peptide Fragments/chemistry , Peptide Fragments/immunology , Protein Binding , Sincalide/chemistry , Sincalide/immunology , Surface Plasmon Resonance , Tyrosine/chemistry , Tyrosine/immunology
17.
J Pept Sci ; 14(8): 903-10, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18320561

ABSTRACT

The chemical synthesis by solid-phase methods of a novel amphiphilic peptide, peptide-conjugate amphiphile (PCA), containing in the same molecule three different functions: (i) the N,N-bis[2-[bis(carboxy-ethyl)amino]ethyl]-L-glutamic acid (DTPAGlu) chelating agent, (ii) the CCK8 bioactive peptide, and (iii) a hydrophobic moiety containing four alkyl chains with 18 carbon atoms each, is reported. In water solution at pH 7.4, PCA self-assembles in very stable micelles at very low concentration [critical micellar concentration (cmc) values of 5 x 10(-7) mol kg(-1)] as confirmed by fluorescence spectroscopy. The structural characterization, obtained with small-angle neutron scattering (SANS) measurements, indicates that the aggregates are substantially represented by ellipsoidal micelles with an aggregation number of 39 +/- 2 and the two micellar axes of about 52 and 26 A.


Subject(s)
Cholecystokinin/chemistry , Micelles , Pentetic Acid/analogs & derivatives , Peptide Fragments/chemistry , Peptides/chemistry , Peptides/chemical synthesis , Sincalide/analogs & derivatives , Surface-Active Agents/chemistry , Surface-Active Agents/chemical synthesis , Hydrophobic and Hydrophilic Interactions , Molecular Structure , Neutron Diffraction , Pentetic Acid/chemistry , Scattering, Small Angle , Sincalide/chemistry , Solutions/chemistry , Spectrometry, Fluorescence , Water/chemistry
18.
Biopolymers ; 88(2): 115-21, 2007.
Article in English | MEDLINE | ID: mdl-17154288

ABSTRACT

The self-assembling behavior, at physiological pH, of the amphiphile peptide (C18)(2)L5CCK8 in nanostructures is reported. Stable aggregates presenting a critical micellar concentration of 2 x 10(-6) mol kg(-1), and characterized by water exposed CCK8 peptide in beta-sheet conformation, are obtained. Small angle neutron scattering experiments are indicative for a 3D structure with dimensions > or =100 nm. AFM images confirm the presence of nanostructures. Fluorescence experiments indicating the sequestration of pyrene, chosen as drug model, and the anticancer Doxorubicin within the nanostructures are reported.


Subject(s)
Drug Carriers/chemistry , Nanostructures/chemistry , Sincalide/analogs & derivatives , Antineoplastic Agents/administration & dosage , Circular Dichroism , Doxorubicin/administration & dosage , Microscopy, Atomic Force , Nanotechnology , Neutron Diffraction , Scattering, Small Angle , Sincalide/chemistry , Spectrometry, Fluorescence , Surface-Active Agents/chemistry
19.
Amino Acids ; 33(1): 91-6, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17058117

ABSTRACT

Two enzymatically synthetic strategies of the tripeptide derivative PhAc-Asp(OMe)-Tyr-Met-OAl are reported. The second strategy gains the advantage of more economical starting materials, less reaction steps and a higher overall isolated yield of this tripeptide fragment over the first strategy. The effect of the acyl-donor ester concentration and structure, the C-alpha protecting group of the nucleophile, reaction media, enzyme and the carrier on the tripeptide derivative synthesis were studied. This tripeptide selected is a fragment of the cholecystokinin C-terminal octapeptide (CCK-8), a potential therapeutic agent in the control of gastrointestinal function and also a drug candidate for the treatment of epilepsy.


Subject(s)
Chymotrypsin/metabolism , Oligopeptides/chemical synthesis , Papain/metabolism , Sincalide/chemistry , Thermolysin/pharmacology , Peptide Fragments/chemical synthesis
20.
Biochemistry ; 45(49): 14706-16, 2006 Dec 12.
Article in English | MEDLINE | ID: mdl-17144663

ABSTRACT

Oligomerization of the G protein-coupled cholecystokinin (CCK) receptor has been demonstrated, but its molecular basis and functional importance are not clear. We now examine contributions of transmembrane (TM) segments to oligomerization of this receptor using a peptide competitive inhibition strategy. Oligomerization of CCK receptors tagged at the carboxyl terminus with Renilla luciferase or yellow fluorescent protein was quantified using bioluminescence resonance energy transfer (BRET). Synthetic peptides representing TM I, II, V, VI, and VII of the CCK receptor were utilized as competitors. Of these, only TM VI and VII peptides disrupted receptor BRET. Control studies established that the beta2-adrenergic receptor TM VI peptide that disrupts oligomerization of that receptor had no effect on CCK receptor BRET. Notably, disruption of CCK receptor oligomerization had no effect on agonist binding, biological activity, or receptor internalization. To gain insight into the face of TM VI contributing to oligomerization, we utilized analogous peptides with alanines in positions 315, 319, and 323 (interhelical face) or 317, 321, and 325 (external lipid-exposed face). The Ala317,321,325 peptide eliminated the disruptive effect on CCK receptor BRET, whereas the other mutant peptide behaved like wild-type TM VI. This suggests that the lipid-exposed face of the CCK receptor TM VI most contributes to oligomerization and supports external contact dimerization of helical bundles, rather than domain-swapped dimerization. Fluorescent CCK receptor mutants with residues 317, 321, and 325 replaced with alanines were also prepared and failed to yield significant resonance transfer signals using either BRET or a morphological FRET assay, further supporting this interpretation.


Subject(s)
Receptors, Cholecystokinin/chemistry , Receptors, Cholecystokinin/metabolism , Amino Acid Sequence , Animals , Kinetics , Luciferases/metabolism , Models, Molecular , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Conformation , Renilla/enzymology , Sincalide/chemistry , Sincalide/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...